Lupus

Top Story

FDA's hydroxychloroquine emergency use order for COVID-19 draws mixed reactions

FDA's hydroxychloroquine emergency use order for COVID-19 draws mixed reactions
April 3, 2020

ACR, rheumatology societies call on governors to safeguard hydroxychloroquine supply chain

April 2, 2020
More than 50 rheumatology societies, including the American College of Rheumatology, have urged U.S. governors to ensure judicious use of hydroxychloroquine and…
In the Journals

COVID-19 Global Rheumatology Alliance discourages off-label use of hydroxychloroquine

March 31, 2020
An international group of more than a dozen rheumatologists have cosigned an article published in Annals of Internal Medicine discouraging the off-label use of…
Feature

ACR issues guidelines to ensure hydroxychloroquine supply, patient access amid COVID-19 demand

March 30, 2020
In the wake of increasing reports of hydroxychloroquine shortages in the United States, sparked by its still-untested potential as a COVID-19 treatment, the American…
More Headlines »